期刊文献+

IL-13和替代激活的巨噬细胞在纤维化中的作用 被引量:3

The role of IL-13 and alternative activated macrophages in fibrosis
原文传递
导出
摘要 纤维化是由于炎症导致器官实质细胞发生坏死,纤维结缔组织异常增多和过度沉积的病理过程.大量的研究表明,IL-13参与了纤维化的发生发展过程,其各种功能通过复杂受体系统来完成,包括IL-13受体a1(IL-13 Ra1),IL-4受体(IL-4R)和IL-13受体a2(IL-13Ra2).此外,IL-13和IL-4可激活巨噬细胞表型转变为替代激活的巨噬细胞,发挥促纤维化的作用,现概括介绍IL-13及其受体、替代激活的巨噬细胞在纤维化中的作用研究的新进展. Fibrosis results from inflammation,which triggers necrosis of organ parenchymal cells and excessive deposits of fibrous connective tissue.Numerous studies have suggested that Interleukin 13 (IL-13)involves in the process of fibrosis.Its diverse fuctions are mediated by a complicated receptor system in IL-13 receptor a1 (IL-13Ra1),IL-4 receptor a(IL-4R),and IL-13 receptor a2(IL-13Ra2).In addition,IL-13 and IL-4 induce alternative activation of macrophages to promote fibrosis.This review focuses on the roles of IL-13,its receptors,and macrophage in fibrosis alternative activation macrophages in fibrosis.
作者 刘奇 胡志伟
出处 《国际免疫学杂志》 CAS 2014年第2期145-148,共4页 International Journal of Immunology
关键词 白细胞介素-13 白细胞介素-4 巨噬细胞 替代激活的巨噬细胞 纤维化 INTERLEUKIN 13 INTERLEUKIN 4 Macrophages Alternative activated macrophages Fibrosis
  • 相关文献

参考文献29

  • 1Mannon P, Reinisch W. Interleukin 13 and its role in gut defenceand inflammation[J] . Gut ,2012 ,61 (12) : 1765-1773.
  • 2Campbell-Harding G,Sawkins H,Bedke N,et al. The innate anti-viral response upregulates IL-13 receptor alpha2 in bronchial fibro-blasts [J]. J Allergy Clin Immunol,2013,131 (3) : 849-855.
  • 3Chen W, Tabata Y, Gibson AM,et al. Matrix metalloproteinase 8contributes to solubilization of IL-13 receptor alpha2 in vivo[J]. JAllergy Clin Immunol,2008,122(3) : 625-632.
  • 4Chen W,Sivaprasad U,Tabata Y,et al. IL-13R alpha 2 membraneand soluble isoforms differ in humans and mice[J] . J Immunol,2009,183(12) : 7870-7876.
  • 5Chen W, Sivaprasad U, Gibson AM,et al. IL-13 receptor alpha2contributes to development of experimental allergic asthma[J]. JAllergy Clin Immunol,2013 ,132(4) : 951-958.
  • 6Chawla A. Control of macrophage activation and function byPPARs[J]. Circ Res,2010,106(10) : 1559-1569.
  • 7黄自坤,李俊明.巨噬细胞极化及其在感染性疾病中的作用[J].国际免疫学杂志,2012,35(4):255-258. 被引量:11
  • 8Liu G,Yang H. Modulation of macrophage activation and program-ming in immunity [J]. J Cell Physiol,2013 ,228 (3 ) : 502-512.
  • 9Gordon S, Martinez FO, Alternative activation of macrophages:mechanism and functions[J]. Immunity,2010,32(5) : 593-604.
  • 10Lee CG,Homer RJ,Zhu Z,et al. Interleukin-13 induces tissue fi-brosis by selectively stimulating and activating transforminggrowth factor beta ( 1 ) [J] . J Exp Med,2001, 194 ( 6 ) : 809-821.

二级参考文献51

  • 1Luo MH, Li YS, Yang KP. Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation. Cardiology, 2007,107:248-253.
  • 2Kallergis EM, Manios EG, Kanoupakis EM, et al. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. J Am Coll Cardiol, 2008, 52:211-215.
  • 3Boldt A, Wetzel U, Lauschke J, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart, 2004, 90:400-405.
  • 4Timonen P, Magga J, Risteli J, et al. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy . Int J Cardiol, 2008, 124:293-300.
  • 5Goette A, Staack T, Rocken C, et al. Increased expression of extracellular sigual-regulated kinase and angiotensin-converting enzyme in human atrial during atrial fibrillation. J Am Coll Cardial, 2000, 35:1669-1677.
  • 6Xiao HD, Fuchs S, Campbell DJ, et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol, 2004, 165:1019-1032.
  • 7Shi Y, Li D, Tardif JC, et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res, 2002, 54:456-461.
  • 8Hirayama Y, Atarashi H, Kobayashi Y, et al. Angiotensinconverting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J, 2005, 69:671-676.
  • 9Madrid AH, Escobar C, Rebollo JM, et al. Angiotensin recep- tor blocker as adjunctive therapy for rhythm control in atrial fibrillation : results of the irbesartan-amiodarone trial. Card Electrophysiol Rev, 2003, 7:243-246.
  • 10Zaman AG, Kearney MT, Schecter C, et al. Angiotensin- convetting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. Am Heart J, 2004, 147 : 823- 827.

共引文献11

同被引文献35

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部